Literature DB >> 29721988

Role of Sirtuins in Retinal Function Under Basal Conditions.

Jonathan B Lin1,2, Shunsuke Kubota1, Raul Mostoslavsky3, Rajendra S Apte4,5,6.   

Abstract

Sirtuins are NAD+-dependent enzymes that govern cellular homeostasis by regulating the acylation status of their diverse target proteins. We recently demonstrated that both rod and cone photoreceptors rely on NAMPT-mediated NAD+ biosynthesis to meet their energetic requirements. Moreover, we found that this NAD+-dependent retinal homeostasis relies, in part, on maintenance of optimal activity of the mitochondrial sirtuins and of SIRT3 in particular. Nonetheless, it is unknown whether other sirtuin family members also play important roles in retinal homeostasis. Our results suggest that SIRT1, SIRT2, SIRT4, and SIRT6 are dispensable for retinal survival at baseline, as individual deletion of each of these sirtuins does not cause retinal degeneration by fundus biomicroscopy or retinal dysfunction by ERG. These findings have significant implications and inform future studies investigating the mechanisms underlying the central role of NAD+ biosynthesis in retinal survival and function.

Entities:  

Keywords:  NAD+; Neurodegeneration; Photoreceptors; Retina; Retinal degeneration; Sirtuins

Mesh:

Substances:

Year:  2018        PMID: 29721988      PMCID: PMC6276360          DOI: 10.1007/978-3-319-75402-4_68

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  21 in total

1.  Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.

Authors:  Raul Mostoslavsky; Katrin F Chua; David B Lombard; Wendy W Pang; Miriam R Fischer; Lionel Gellon; Pingfang Liu; Gustavo Mostoslavsky; Sonia Franco; Michael M Murphy; Kevin D Mills; Parin Patel; Joyce T Hsu; Andrew L Hong; Ethan Ford; Hwei-Ling Cheng; Caitlin Kennedy; Nomeli Nunez; Roderick Bronson; David Frendewey; Wojtek Auerbach; David Valenzuela; Margaret Karow; Michael O Hottiger; Stephen Hursting; J Carl Barrett; Leonard Guarente; Richard Mulligan; Bruce Demple; George D Yancopoulos; Frederick W Alt
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

2.  Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1.

Authors:  Masaya Tanno; Jun Sakamoto; Tetsuji Miura; Kazuaki Shimamoto; Yoshiyuki Horio
Journal:  J Biol Chem       Date:  2006-12-30       Impact factor: 5.157

3.  Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase.

Authors:  Gregory Liszt; Ethan Ford; Martin Kurtev; Leonard Guarente
Journal:  J Biol Chem       Date:  2005-03-28       Impact factor: 5.157

4.  SIRT1 promotes RGC survival and delays loss of function following optic nerve crush.

Authors:  Ling Zuo; Reas S Khan; Vivian Lee; Kimberly Dine; Wen Wu; Kenneth S Shindler
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-26       Impact factor: 4.799

5.  Rhodopsin-iCre transgenic mouse line for Cre-mediated rod-specific gene targeting.

Authors:  Sha Li; Desheng Chen; Yves Sauvé; Jeremy McCandless; Yu-Jiun Chen; Ching-Kang Chen
Journal:  Genesis       Date:  2005-02       Impact factor: 2.487

6.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.

Authors:  S Imai; C M Armstrong; M Kaeberlein; L Guarente
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

7.  NAMPT-Mediated NAD(+) Biosynthesis Is Essential for Vision In Mice.

Authors:  Jonathan B Lin; Shunsuke Kubota; Norimitsu Ban; Mitsukuni Yoshida; Andrea Santeford; Abdoulaye Sene; Rei Nakamura; Nicole Zapata; Miyuki Kubota; Kazuo Tsubota; Jun Yoshino; Shin-Ichiro Imai; Rajendra S Apte
Journal:  Cell Rep       Date:  2016-09-27       Impact factor: 9.423

8.  The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase.

Authors:  Bjorn Schwer; Brian J North; Roy A Frye; Melanie Ott; Eric Verdin
Journal:  J Cell Biol       Date:  2002-08-19       Impact factor: 10.539

9.  Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis.

Authors:  Brian J North; Eric Verdin
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

10.  SIRT6 is required for normal retinal function.

Authors:  Dafne M Silberman; Kenneth Ross; Pablo H Sande; Shunsuke Kubota; Sridhar Ramaswamy; Rajendra S Apte; Raul Mostoslavsky
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

View more
  5 in total

Review 1.  NAD+ metabolism and retinal degeneration (Review).

Authors:  Andreea Silvia Pîrvu; Ana Marina Andrei; Elena Camelia Stănciulescu; Ileana Monica Baniță; Cătălina Gabriela Pisoschi; Sanda Jurja; Radu Ciuluvica
Journal:  Exp Ther Med       Date:  2021-04-23       Impact factor: 2.447

2.  Extracellular Vesicle-Contained eNAMPT Delays Aging and Extends Lifespan in Mice.

Authors:  Mitsukuni Yoshida; Akiko Satoh; Jonathan B Lin; Kathryn F Mills; Yo Sasaki; Nicholas Rensing; Michael Wong; Rajendra S Apte; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2019-06-13       Impact factor: 27.287

3.  Selective Upregulation of SIRT1 Expression in Retinal Ganglion Cells by AAV-Mediated Gene Delivery Increases Neuronal Cell Survival and Alleviates Axon Demyelination Associated with Optic Neuritis.

Authors:  Ahmara G Ross; Brahim Chaqour; Devin S McDougald; Kimberly E Dine; Thu T Duong; Ryan E Shindler; Jipeng Yue; Tehui Liu; Kenneth S Shindler
Journal:  Biomolecules       Date:  2022-06-14

4.  SIRT4 Is Highly Expressed in Retinal Müller Glial Cells.

Authors:  Wei Wei; Piaopiao Hu; Mengqi Qin; Guiping Chen; Feifei Wang; Shengrui Yao; Ming Jin; Zhi Xie; Xu Zhang
Journal:  Front Neurosci       Date:  2022-02-04       Impact factor: 4.677

5.  Systemic Treatment With Nicotinamide Riboside Is Protective in a Mouse Model of Light-Induced Retinal Degeneration.

Authors:  Xian Zhang; Nathaniel F Henneman; Preston E Girardot; Jana T Sellers; Micah A Chrenek; Ying Li; Jiaxing Wang; Charles Brenner; John M Nickerson; Jeffrey H Boatright
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.